1. Overview
Erlotinib is a targeted cancer medicine used to treat certain types of lung and pancreatic cancers. It works by slowing or stopping the growth of cancer cells, helping to manage the disease and improve patient outcomes.
2. How It Works
Erlotinib blocks a protein called epidermal growth factor receptor (EGFR) that signals cancer cells to grow and divide. By inhibiting this protein, it reduces cancer cell growth and helps control tumor progression.
3. Common Uses
- Non-small cell lung cancer (NSCLC) with EGFR mutation
- Pancreatic cancer (in combination with other treatments)
4. Key Benefits
- Targets cancer cells specifically, helping slow tumor growth
- Can be taken orally as a daily tablet
- May improve progression-free survival in eligible patients
5. Safety & Precautions
- Take exactly as prescribed by your oncologist
- Avoid missing doses; do not double the dose if missed
- Watch for side effects such as rash, diarrhea, or liver changes
- Inform your doctor about other medications or health conditions
6. Scientific Literature (External Links)
- Erlotinib in lung cancer: https://pubmed.ncbi.nlm.nih.gov/17318289/
- EGFR inhibition mechanism: https://pubmed.ncbi.nlm.nih.gov/15564084/
- Erlotinib in pancreatic cancer: https://pubmed.ncbi.nlm.nih.gov/17088249/
These details are compiled from publicly available scientific sources. MYMEDS.MD is not liable for clinical interpretation. Please consult a licensed medical practitioner for personalised guidance.